Imunon Analyst Price Targets

Imunon Inc

IMNNNASDAQ

Trade with Public

$0.9850

-0.035-3.43%

Últ. Act.: Oct 19, 4:13 PM

$0.9800

-0.04-3.92%

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Informe de acciones

Imunon Analyst Price Targets

Wall Street analyst price targets and consensus rating for Imunon (IMNN).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

3Buy

1Hold

Consensus RatingBuy# Analysts4Avg. Consensus PT$190Upside to Avg. PT+19317.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Apr 17, 2026	Maxim Group	Jason McCarthy	Initiate	Buy	$10
May 19, 2025	D. Boral Capital	Jason Kolbert	Downgrade	Buy→Hold	—
May 13, 2025	D. Boral Capital	Jason Kolbert	PT Cut	Buy	$29→$17
May 7, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$29
Mar 26, 2025	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$14
Mar 24, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$29
Feb 27, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$29
Feb 19, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$29
Jan 24, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$29
Dec 19, 2024	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$12
Dec 19, 2024	D. Boral Capital	Jason Kolbert	Maintained	Buy	$29
Dec 11, 2024	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$12
Dec 10, 2024	D. Boral Capital	Jason Kolbert	Maintained	Buy	$29
Nov 25, 2024	D. Boral Capital	Jason Kolbert	Maintained	Buy	$29
Nov 11, 2024	HC Wainwright & Co.	Emily Bodnar	PT Cut	Buy	$14→$12
Nov 7, 2024	EF Hutton	Jason Kolbert	Maintained	Buy	$29
Oct 31, 2024	EF Hutton	Jason Kolbert	Maintained	Buy	$29
Sep 23, 2024	EF Hutton	Jason Kolbert	Initiate	Buy	$29
Aug 15, 2024	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$14
Aug 5, 2024	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$12→$14

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $25 Price Valuation

Benzinga Newsdesk

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $25 Price Valuation

Benzinga Newsdesk

PRO
Maxim Group Initiates Coverage On Imunon with Buy Rating, Announces Price Target of $10

Maxim Group analyst Jason McCarthy initiates coverage on Imunon (NASDAQ:IMNN) with a Buy rating and announces Price Target of $10.

Benzinga Newsdesk

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $33 Price Valuation

https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_03252026_IMNN_Bautz.pdf

Benzinga Newsdesk

PRO
D. Boral Capital Downgrades Imunon to Hold

D. Boral Capital analyst Jason Kolbert downgrades Imunon (NASDAQ:IMNN) from Buy to Hold.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Imunon, Lowers Price Target to $17

D. Boral Capital analyst Jason Kolbert maintains Imunon (NASDAQ:IMNN) with a Buy and lowers the price target from $29 to $17.

Benzinga Newsdesk

Imunon Inc

Imunon Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $25 Price Valuation

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $25 Price Valuation

PRO
Maxim Group Initiates Coverage On Imunon with Buy Rating, Announces Price Target of $10

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $33 Price Valuation

PRO
D. Boral Capital Downgrades Imunon to Hold

PRO
D. Boral Capital Maintains Buy on Imunon, Lowers Price Target to $17

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Imunon Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $25 Price Valuation

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $25 Price Valuation

PRO
Maxim Group Initiates Coverage On Imunon with Buy Rating, Announces Price Target of $10

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $33 Price Valuation

PRO
D. Boral Capital Downgrades Imunon to Hold

PRO
D. Boral Capital Maintains Buy on Imunon, Lowers Price Target to $17

People Also Watch

People Also Watch

Imunon Inc

Imunon Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROWatching Imunon; Zacks Small-Cap Research Gives Stock $25 Price Valuation

PROWatching Imunon; Zacks Small-Cap Research Gives Stock $25 Price Valuation

PROMaxim Group Initiates Coverage On Imunon with Buy Rating, Announces Price Target of $10

PROWatching Imunon; Zacks Small-Cap Research Gives Stock $33 Price Valuation

PROD. Boral Capital Downgrades Imunon to Hold

PROD. Boral Capital Maintains Buy on Imunon, Lowers Price Target to $17

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Imunon Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROWatching Imunon; Zacks Small-Cap Research Gives Stock $25 Price Valuation

PROWatching Imunon; Zacks Small-Cap Research Gives Stock $25 Price Valuation

PROMaxim Group Initiates Coverage On Imunon with Buy Rating, Announces Price Target of $10

PROWatching Imunon; Zacks Small-Cap Research Gives Stock $33 Price Valuation

PROD. Boral Capital Downgrades Imunon to Hold

PROD. Boral Capital Maintains Buy on Imunon, Lowers Price Target to $17

People Also Watch

People Also Watch

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $25 Price Valuation

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $25 Price Valuation

PRO
Maxim Group Initiates Coverage On Imunon with Buy Rating, Announces Price Target of $10

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $33 Price Valuation

PRO
D. Boral Capital Downgrades Imunon to Hold

PRO
D. Boral Capital Maintains Buy on Imunon, Lowers Price Target to $17

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $25 Price Valuation

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $25 Price Valuation

PRO
Maxim Group Initiates Coverage On Imunon with Buy Rating, Announces Price Target of $10

PRO
Watching Imunon; Zacks Small-Cap Research Gives Stock $33 Price Valuation

PRO
D. Boral Capital Downgrades Imunon to Hold

PRO
D. Boral Capital Maintains Buy on Imunon, Lowers Price Target to $17